In rats given BPC-157, serotonin levels in the brain increase in specific regions while simultaneously decreasing in other regions, such as the hippocampus.[ref] A 2020 study found that BPC-157 reduced leaky gut syndrome by stabilizing gut permeability after NSAID use.[ref] Reducing leaky gut theoretically can affect the gut-brain axis and reduce inflammation
Even more specifically, rats studied predominantly by one research group in Zagreb, Croatia
Compared to oral supplements, this leads to quicker and more effective results
They simply mask the symptoms
"Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health." Journal of Endocrinology and Metabolism, vol
Related links Cancer Hotspots: ClinicalTrials.gov: GLOBOCAN: National Comprehensive Cancer Network (NCCN) Guidelines for NSCLC: OncoKB: Rights and permissions Springer Nature or its licensor (e.g